These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22185023)

  • 1. [Clinical implication of endothelial dysfunction in patients with essential arterial hypertension and urate dysbolism with renal damage].
    Ter Arkh; 2011; 83(10):36-40. PubMed ID: 22185023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial function in patients with arterial hypertension and impaired uric acid metabolism].
    Lebedeva MV; Stakhova TIu; Minakova EG; Zaĭtseva LI; Severova MM; Pulin AA
    Vestn Ross Akad Med Nauk; 2010; (12):44-6. PubMed ID: 21395065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders].
    Stakhova TIu; Shcherbak AV; Kozlovskaia LV; Taranova MV; Balkarov IM
    Ter Arkh; 2014; 86(6):45-51. PubMed ID: 25095655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
    Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
    Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Falqui V; Parodi A; Conti N; Derchi LE; Tomolillo C; Deferrari G; Pontremoli R
    Am J Hypertens; 2007 Dec; 20(12):1276-82. PubMed ID: 18047917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Markers of vascular endothelium activation in gout].
    Lapkina NA; Baranov AA; Barskova VG; Abaĭtova NE; Iakunina IA
    Ter Arkh; 2005; 77(5):62-5. PubMed ID: 15989007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?].
    Petriş A; Cimpoeşu D; Petriş O; Costache I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure.
    Cottone S; Mulè G; Amato F; Riccobene R; Vadalà A; Lorito MC; Raspanti F; Cerasola G
    J Nephrol; 2002; 15(6):643-8. PubMed ID: 12495277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
    Karbowska A; Boratynska M; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers.
    Berni A; Boddi M; Fattori EB; Cecioni I; Berardino S; Montuschi F; Chiostri M; Poggesi L
    Am J Hypertens; 2010 Jun; 23(6):675-80. PubMed ID: 20203626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
    Rodilla E; Pérez-Lahiguera F; Costa JA; González C; Miralles A; Moral D; Pascual JM
    Med Clin (Barc); 2009 Jan; 132(1):1-6. PubMed ID: 19174057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in patients with noncomplicated and complicated hypertension.
    Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
    Clin Exp Hypertens; 2009 Feb; 31(1):20-30. PubMed ID: 19172456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction.
    Vlachopoulos C; Aznaouridis K; Ioakeimidis N; Rokkas K; Tsekoura D; Vasiliadou C; Stefanadi E; Askitis A; Stefanadis C
    J Hypertens; 2008 Sep; 26(9):1829-36. PubMed ID: 18698219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum uric acid levels impair coronary microvascular function in patients with idiopathic dilated cardiomyopathy.
    Gullu H; Erdogan D; Caliskan M; Tok D; Kulaksizoglu S; Yildirir A; Muderrisoglu H
    Eur J Heart Fail; 2007 May; 9(5):466-8. PubMed ID: 17169608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
    Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
    Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.